The global market for osteoporosis diagnostic products is expected to expand from $253m in 2015 to $304m by 2020, fueled by a rising aging population and the need to test for osteoporosis and associated fracture risk. This article offers an in-depth look at the growth markets for both bone densitometer testing and biochemical marker tests, as well as the evolving competitive landscape, and the drivers and barriers to market entry.
The demand for products to diagnose osteoporosis – in particular, bone densitometer devices – continues to rise globally amid the growing aging population and high incidence rates of osteoporosis and associated fractures.
According to Datamonitor Healthcare, the number of adults with osteoporosis in the US will climb from 9.8 million in 2015 to an estimated 11 million in 2020, then to 13.3...